Abstract
Prenatal exposure to the antiepileptic, mood-stabilizing drug, valproic acid (VPA), increases the incidence of autism spectrum disorders (ASDs); in utero administration of VPA to pregnant rodents induces ASD-like behaviors such as repetitive, stereotyped activity, and decreased socialization. In both cases, males are more affected than females. We previously reported that VPA, administered to pregnant mice at gestational day 12.5, rapidly induces a transient, 6-fold increase in BDNF (brain-derived neurotrophic factor) protein and mRNA in the fetal brain. Here, we investigate sex differences in the induction of Bdnf expression by VPA as well as the underlying epigenetic mechanisms. We found no sex differences in the VPA stimulation of total brain Bdnf mRNA as indicated by probing for the BDNF protein coding sequence (exon 9); however, stimulation of individual transcripts containing two of the nine 5′-untranslated exons (5′UTEs) in Bdnf (exons 1 and 4) by VPA was greater in female fetal brains. These Bdnf transcripts have been associated with different cell types or subcellular compartments within neurons. Since VPA is a histone deacetylase inhibitor, covalent histone modifications at Bdnf 5′UTEs in the fetal brain were analyzed by chromatin immunoprecipitation. VPA increased the acetylation of multiple H3 and H4 lysine residues in the vicinity of exons 1, 2, 4, and 6; minimal differences between the sexes were observed. H3 lysine 4 trimethylation (H3K4me3) at those exons was also stimulated by VPA. Moreover, the VPA-induced increase in H3K4me3 at exons 1, 4, and 6 was significantly greater in females than in males, i.e., sexually dimorphic stimulation of H3K4me3 by VPA correlated with Bdnf transcripts containing exons 1 and 4, but not 6. Neither H3K27me3 nor cytosine methylation at any of the 117 CpGs in the vicinity of the transcription start sites of exons 1, 4, and 6 was affected by VPA. Thus, of the 6 epigenetic marks analyzed, only H3K4me3 can account for the sexually dimorphic expression of Bdnf transcripts induced by VPA in the fetal brain. Preferential expression of exon 1- and exon 4-Bdnf transcripts in females may contribute to sex differences in ASDs by protecting females from the adverse effects of genetic variants or environmental factors such as VPA on the developing brain.
References
1.
Chawarska K, Macari S, Shic F: Decreased spontaneous attention to social scenes in 6-month-old infants later diagnosed with autism spectrum disorders. Biol Psychiatry 2013;74:195-203.
2.
Surén P, Roth C, Bresnahan M, Haugen M, Hornig M, Hirtz D, et al: Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA 2013;309:570-577.
3.
Virk J, Liew Z, Olsen J, Nohr EA, Catov JM, Ritz B: Preconceptional and prenatal supplementary folic acid and multivitamin intake and autism spectrum disorders. Autism Int J Res Pract 2016;20:710-718.
4.
Chang J, Gilman SR, Chiang AH, Sanders SJ, Vitkup D: Genotype to phenotype relationships in autism spectrum disorders. Nat Neurosci 2015;18:191-198.
5.
Budimirovic DB, Kaufmann WE: What can we learn about autism from studying fragile X syndrome? Dev Neurosci 2011;33:379-394.
6.
Arndt TL, Stodgell CJ, Rodier PM: The teratology of autism. Int J Dev Neurosci 2005;23:189-199.
7.
Ploeger A, Raijmakers MEJ, van der Maas HLJ, Galis F: The association between autism and errors in early embryogenesis: what is the causal mechanism? Biol Psychiatry 2010;67:602-607.
8.
Roberts EM, English PB, Grether JK, Windham GC, Somberg L, Wolff C: Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environ Health Perspect 2007;115:1482-1489.
9.
Wisner KL, Leckman-Westin E, Finnerty M, Essock SM: Valproate prescription prevalence among women of childbearing age. Psychiatr Serv 2011;62:218-220.
10.
Bromley RL, Mawer G, Clayton-Smith J, Baker GA: Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 2008;71:1923-1924.
11.
Christensen J, Grønborg TK, Sørensen MJ, Schendel D, Parner ET, Pedersen LH, et al: Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 2013;309:1696-1703.
12.
Gerard EE, Meador KJ: An update on maternal use of antiepileptic medications in pregnancy and neurodevelopment outcomes. J Pediatr Genet 2015;4:94-110.
13.
Moore SJ, Turnpenny P, Quinn A, Glover S, Lloyd DJ, Montgomery T, et al: A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet 2000;37:489-497.
14.
Ornoy A, Weinstein-Fudim L, Ergaz Z: Prenatal factors associated with autism spectrum disorder (ASD). Reprod Toxicol 2015;56:155-169.
15.
Roullet FI, Lai JKY, Foster JA: In utero exposure to valproic acid and autism - a current review of clinical and animal studies. Neurotoxicol Teratol 2013;36:47-56.
16.
Mychasiuk R, Richards S, Nakahashi A, Kolb B, Gibb R: Effects of rat prenatal exposure to valproic acid on behaviour and neuro-anatomy. Dev Neurosci 2012;34:268-276.
17.
Gandal MJ, Edgar JC, Ehrlichman RS, Mehta M, Roberts TPL, Siegel SJ: Validating γ oscillations and delayed auditory responses as translational biomarkers of autism. Biol Psychiatry 2010;68:1100-1106.
18.
Schneider T, Przewłocki R: Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 2005;30:80-89.
19.
Hutsler JJ, Zhang H: Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Res 2010;1309:83-94.
20.
Kataoka S, Takuma K, Hara Y, Maeda Y, Ago Y, Matsuda T: Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid. Int J Neuropsychopharmacol 2013;16:91-103.
21.
Stoner R, Chow ML, Boyle MP, Sunkin SM, Mouton PR, Roy S, et al: Patches of disorganization in the neocortex of children with autism. N Engl J Med 2014;370:1209-1219.
22.
Codagnone MG, Podestá MF, Uccelli NA, Reinés A: Differential local connectivity and neuroinflammation profiles in the medial prefrontal cortex and hippocampus in the valproic acid rat model of autism. Dev Neurosci 2015;37:215-231.
23.
Schneider T, Roman A, Basta-Kaim A, Kubera M, Budziszewska B, Schneider K, et al: Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid. Psychoneuroendocrinology 2008;33:728-740.
24.
Mowery TM, Wilson SM, Kostylev PV, Dina B, Buchholz JB, Prieto AL, et al: Embryological exposure to valproic acid disrupts morphology of the deep cerebellar nuclei in a sexually dimorphic way. Int J Dev Neurosci 2015;40:15-23.
25.
Kim KC, Kim P, Go HS, Choi CS, Park JH, Kim HJ, et al: Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder. J Neurochem 2013;124:832-843.
26.
Almeida LEF, Roby CD, Krueger BK: Increased BDNF expression in fetal brain in the valproic acid model of autism. Mol Cell Neurosci 2014;59:57-62.
27.
Cohen-Cory S, Kidane AH, Shirkey NJ, Marshak S: Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev Neurobiol 2010;70:271-288.
28.
Aid T, Kazantseva A, Piirsoo M, Palm K, Timmusk T: Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res 2007;85:525-535.
29.
Delcuve GP, Khan DH, Davie JR: Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors. Clin Epigenetics 2012;4:5.
30.
Monti B, Polazzi E, Contestabile A: Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. Curr Mol Pharmacol 2009;2:95-109.
31.
Hezroni H, Sailaja BS, Meshorer E: Pluripotency-related, valproic acid (VPA)-induced genome-wide histone H3 lysine 9 (H3K9) acetylation patterns in embryonic stem cells. J Biol Chem 2011;286:35977-35988.
32.
Karmodiya K, Krebs AR, Oulad-Abdelghani M, Kimura H, Tora L: H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells. BMC Genomics 2012;13:424.
33.
Yao B, Christian KM, He C, Jin P, Ming G-L, Song H: Epigenetic mechanisms in neurogenesis. Nat Rev Neurosci 2016;17:537-549.
34.
Kumamaru E, Egashira Y, Takenaka R, Takamori S: Valproic acid selectively suppresses the formation of inhibitory synapses in cultured cortical neurons. Neurosci Lett 2014;569:142-147.
35.
Moldrich RX, Leanage G, She D, Dolan-Evans E, Nelson M, Reza N, Reutens DC: Inhibition of histone deacetylase in utero causes sociability deficits in postnatal mice. Behav Brain Res 2013;257:253-264.
36.
Ishimaru N, Fukuchi M, Hirai A, Chiba Y, Tamura T, Takahashi N, et al: Differential epigenetic regulation of BDNF and NT-3 genes by trichostatin A and 5-aza-2′-deoxycytidine in Neuro-2a cells. Biochem Biophys Res Commun 2010;394:173-177.
37.
Suganuma T, Workman JL: Crosstalk among histone modifications. Cell 2008;135:604-607.
38.
Berger SL: The complex language of chromatin regulation during transcription. Nature 2007;447:407-412.
39.
Schaafsma SM, Pfaff DW: Etiologies underlying sex differences in autism spectrum disorders. Front Neuroendocrinol 2014;35:255-271.
40.
Lubin FD, Roth TL, Sweatt JD: Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory. J Neurosci 2008;28:10576-10586.
41.
Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y, et al: DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 2003;302:890-893.
42.
Ratnu VS, Emami MR, Bredy TW: Genetic and epigenetic factors underlying sex differences in the regulation of gene expression in the brain. J Neurosci Res 2017;95:301-310.
43.
Richardson L, Venkataraman S, Stevenson P, Yang Y, Moss J, Graham L, et al: EMAGE mouse embryo spatial gene expression database: 2014 update. Nucleic Acids Res 2014;42:D835-D844.
44.
Umlauf D, Goto Y, Wagschal A, Arnaud P, Feil R, Lewis A: Epigenome NoE - protocol: chromatin immunoprecipitation on native chromatin from cells and tissues. The Epigenome Network of Excellence, 2005. http://www.epigenome-noe.net/researchtools/protocol.php_protid=22.html.
45.
Chen WG, West AE, Tao X, Corfas G, Szentirmay MN, Sawadogo M, et al: Upstream stimulatory factors are mediators of Ca2+-responsive transcription in neurons. J Neurosci 2003;23:2572-2581.
46.
Du J, Patel DJ: Structural biology-based insights into combinatorial readout and crosstalk among epigenetic marks. Biochim Biophys Acta 2014;1839:719-727.
47.
Huang P-H, Plass C, Chen C-S: Effects of histone deacetylase inhibitors on modulating H3K4 methylation marks - a novel cross-talk mechanism between histone-modifying enzymes. Mol Cell Pharmacol 2011;3:39-43.
48.
Nightingale KP, Gendreizig S, White DA, Bradbury C, Hollfelder F, Turner BM: Cross-talk between histone modifications in response to histone deacetylase inhibitors: MLL4 links histone H3 acetylation and histone H3K4 methylation. J Biol Chem 2007;282:4408-4416.
49.
Harikumar A, Meshorer E: Chromatin remodeling and bivalent histone modifications in embryonic stem cells. EMBO Rep 2015;16:1609-1619.
50.
Cedar H, Bergman Y: Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009;10:295-304.
51.
Kondo Y: Epigenetic cross-talk between DNA methylation and histone modifications in human cancers. Yonsei Med J 2009;50:455-463.
52.
Vaissière T, Sawan C, Herceg Z: Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat Res 2008;659:40-48.
53.
Sugathan A, Waxman DJ: Genome-wide analysis of chromatin states reveals distinct mechanisms of sex-dependent gene regulation in male and female mouse liver. Mol Cell Biol 2013;33:3594-3610.
54.
Shen EY, Ahern TH, Cheung I, Straubhaar J, Dincer A, Houston I, et al: Epigenetics and sex differences in the brain: a genome-wide comparison of histone-3 lysine-4 trimethylation (H3K4me3) in male and female mice. Exp Neurol 2015;268:21-29.
55.
Sachs M, Onodera C, Blaschke K, Ebata KT, Song JS, Ramalho-Santos M: Bivalent chromatin marks developmental regulatory genes in the mouse embryonic germline in vivo. Cell Rep 2013;3:1777-1784.
56.
Lister R, Mukamel EA, Nery JR, Urich M, Puddifoot CA, Johnson ND, et al: Global epigenomic reconfiguration during mammalian brain development. Science 2013;341:1237905.
57.
Boros J, Donaldson IJ, O'Donnell A, Odrowaz ZA, Zeef L, Lupien M, et al: Elucidation of the ELK1 target gene network reveals a role in the coordinate regulation of core components of the gene regulation machinery. Genome Res 2009;19:1963-1973.
58.
Odrowaz Z, Sharrocks AD: ELK1 uses different DNA binding modes to regulate functionally distinct classes of target genes. PLoS Genet 2012;8:e1002694.
59.
Steinberger A, Steinberger E: Testicular Development, Structure, and Function. New York, Raven Press, 1980.
60.
Habert R, Picon R: Testosterone, dihydrotestosterone and estradiol-17 beta levels in maternal and fetal plasma and in fetal testes in the rat. J Steroid Biochem 1984;21:193-198.
61.
Wolstenholme JT, Rissman EF, Bekiranov S: Sexual differentiation in the developing mouse brain: contributions of sex chromosome genes. Genes Brain Behav 2013;12:166-180.
62.
Sheardown S, Norris D, Fisher A, Brockdorff N: The mouse Smcx gene exhibits developmental and tissue specific variation in degree of escape from X inactivation. Hum Mol Genet 1996;5:1355-1360.
63.
Yang F, Babak T, Shendure J, Disteche CM: Global survey of escape from X inactivation by RNA-sequencing in mouse. Genome Res 2010;20:614-622.
64.
Adegbola A, Gao H, Sommer S, Browning M: A novel mutation in JARID1C/SMCX in a patient with autism spectrum disorder (ASD). Am J Med Genet A 2008;146A:505-511.
65.
Baj G, Leone E, Chao MV, Tongiorgi E: Spatial segregation of BDNF transcripts enables BDNF to differentially shape distinct dendritic compartments. Proc Natl Acad Sci USA 2011;108:16813-16818.
66.
Maynard KR, Hill JL, Calcaterra NE, Palko ME, Kardian A, Paredes D, et al: Functional role of BDNF production from unique promoters in aggression and serotonin signaling. Neuropsychopharmacology 2016;41:1943-1955.
67.
Maynard KR, Hobbs JW, Sukumar M, Kardian AS, Jimenez DV, Schloesser RJ, Martinowich K: Bdnf mRNA splice variants differentially impact CA1 and CA3 dendrite complexity and spine morphology in the hippocampus. Brain Struct Funct 2017;222:3295-3307.
68.
Kawanai T, Ago Y, Watanabe R, Inoue A, Taruta A, Onaka Y, et al: Prenatal exposure to histone deacetylase inhibitors affects gene expression of autism-related molecules and delays neuronal maturation. Neurochem Res 2016;41:2574-2584.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
